Kelly E Dunn

6PUBLICATIONS
10CO-AUTHORS
PharmacogenomicsEpidemiological modellingLearning, motivation and emotionEvolutionary psychological studiesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 27, 2026
Mediators of treatment response in a clinical trial of naltrexone and bupropion for methamphetamine use disorder: A longitudinal mediation analysis.

|Dec 27, 2024
Application of Causal Forest Model to Examine Treatment Effect Heterogeneity in Substance Use Disorder Psychosocial Treatments.

Ryoko Susukida, Masoumeh Amin-Esmaeili, Elena Badillo-Goicoechea

|Jul 10, 2024
Trajectories of craving in the course of pharmacotherapy trials for methamphetamine use disorder.

Ramin Mojtabai, Ryoko Susukida, Mehdi Farokhnia

|Jan 25, 2024
Moving forward while looking back: Reflections on the history and future of the journal Experimental and Clinical Psychopharmacology.

Kelly E Dunn

|Jan 15, 2024
Polymorphisms in the A118G SNP of the OPRM1 gene produce different experiences of opioids: A human laboratory phenotype-genotype assessment.

Kelly E Dunn, Andrew S Huhn, Patrick H Finan

|Oct 09, 2018
Preliminary evidence of different and clinically meaningful opioid withdrawal phenotypes.

Kelly E Dunn, Elise M Weerts, Andrew S Huhn

Pageof 1

Frequent Collaborators

3 joint publications

Ramin Mojtabai

2 joint publications

Masoumeh Amin-Esmaeili

1 joint publications

David Andrew Tompkins

1 joint publications

Mehdi Farokhnia